1. Introduction {#s0005}
===============

The plasma membrane NADH oxidase activity of cerebellar granule neurons represents a disguisable activity producing superoxide anion (O~2~^·-^) as a collateral product of NADH consumption [@bib1], [@bib2], [@bib3], [@bib4]. The plasma membrane constituents associated to this activity are not well defined although it is known that cytochrome *b*~5~ reductase (C*b*~5~R) is one of its major components present at the plasma membrane of rat cerebellar granule neurons in culture and of synaptic plasma membrane vesicles (SPMV) from rat brain [@bib1]. This protein increases its association to lipids rafts in apoptosis [@bib2]. In addition, 1--3 h after apoptosis induction an increment of O~2~^·-^ has been detected at the peripheral neuronal plasma membrane [@bib2]. This event correlates with the observed times for cytochrome *c* (Cyt *c*) release from mitochondria to the cytosol, as soon as 1 h after apoptosis induction, although the maximum peak for its release was found at 3 h [@bib2].

In this work, we described the function of Cyt *c* as activator of the O~2~^·-^ production by C*b*~5~R, as a component of SPMV, and results were experimentally confirmed with two isoforms of human C*b*~5~R. Due to the important role of Cyt *c* redox state in apoptosis and its reduction by C*b*~5~R, we propose a function of C*b*~5~R, as one the main defensive components during apoptosis after Cyt *c* release from mitochondria to the cytosol.

2. Materials and methods {#s0010}
========================

2.1. SPMV preparation {#s0015}
---------------------

Rat brain SPMV were prepared using a standard procedure as described in [@bib1], [@bib3].

2.2. Human C*b*~5~R isoforms cloning {#s0020}
------------------------------------

Cloning of C*b*~5~R isoforms was performed as indicated in [@bib5] using commercially available construct for soluble and primers described in [Supplementary material](#s0100){ref-type="sec"}.

2.3. Purification of recombinant human C*b*~5~R isoforms {#s0025}
--------------------------------------------------------

Clones of C*b*~5~R isoforms were overexpressed in DE3 competent cells (Rosetta Gammi 2, Novagen) and the recombinant protein purified as indicated in [@bib5].

2.4. NADH oxidase activity {#s0030}
--------------------------

NADH oxidase was measured at 37 °C as in [@bib1], [@bib3], [@bib4], [@bib6], [@bib7].

2.5. O~2~ consumption {#s0035}
---------------------

O~2~ consumption was measured using an Oxygraph Plus DW1 (Hansatech instruments) electrode in the same buffer described above, in presence of NADH (50 μM) and purified human recombinant C*b*~5~R isoforms at 37 °C.

2.6. O~2~^·-^ measurement with NBT {#s0040}
----------------------------------

O~2~^·-^ production by C*b*~5~R was calculated measuring the reduction of NBT in the same buffer described above at pH 7.0, with NBT 200 μM and SOD 1 U/mL at 560 nm at 37 °C using a ε of 27.8 mM^−1^ cm^−1^ [@bib8], [@bib9].

2.7. Cyclic voltammetry {#s0045}
-----------------------

Qualitative measurement of the O~2~^·-^ generated by C*b*~5~R was performed by cyclic voltammetry with a pyrolytic graphite electrode using the thin layer technique (membrane cut off 3.5 kDa) [@bib5]. C*b*~5~R (0.6 mM) or albumins (0.6 mM) as a control were loaded onto the electrode. The set up was completed with a silver/silver chloride (Ag/AgCl) reference electrode and a platinum counter electrode to complete the three electrodes cell configuration.

2.8. O~2~^·-^ measurement with DHE {#s0050}
----------------------------------

O~2~^·-^ formation was measured by fluorescence using dihydroethidium (DHE) [@bib10]. Measurements were performed at 37 °C in buffer (pH 7.0) potassium phosphate 20 mM, DTPA 0.1 mM, and DHE 2 μM and Cyt *c* at the concentration indicated in each experiment, using a quartz cuvette. Fluorescence of DHE was measured with 470 nm and 605 nm excitation and emission wavelengths, respectively, and slits of 10 nm. Xanthine/Xanthine oxidase (XA/XO) was used to calibrate the signal.

2.9. C*b*~5~R:Cyt *c* complex formation {#s0055}
---------------------------------------

Complex formation was measured at 37 °C as indicated in [@bib5].

3. Results {#s0060}
==========

3.1. O~2~^·-^ production by SPMV NADH oxidase activity is stimulated by Cyt *c* {#s0065}
-------------------------------------------------------------------------------

We measured the effect of oxidized Cyt *c* (Fe^3+^) on the NADH-dependent O~2~^·-^ production by SPMV with DHE. Addition of Cyt *c* (2.5 μM) to the assay produced more than 3-fold increase in the oxidation of DHE, in the presence of SPMV (7.5 μg/mL) and NADH (50 μM) ([Fig. 1](#f0005){ref-type="fig"}A, continuous line and B). In addition, SOD added to the assay blocked the Cyt *c* stimulated DHE oxidation rate by SPMV ([Fig. 1](#f0005){ref-type="fig"}A, dotted line and B), pointing out that the increased DHE oxidation rate was due to production of O~2~^·-^, as expected for a O~2~^·-^ responsive dye [@bib11]. The effect of a specific antibody against C*b*~5~R (ProteinTech, Cat \#4668234) in this assay was also tested ([Fig. 1](#f0005){ref-type="fig"}A, dashed line and B). The O~2~^·-^ production by SPMV was almost completely inhibited, i.e. ≥ 90 % inhibition, in the presence of the specific antibody against C*b*~5~R. We measured the DHE oxidation rate dependence upon Cyt *c* (Fe^3+^) concentration, in the absence (filled squares) and presence of SOD (1 U/mL) (open squares) ([Fig. 1](#f0005){ref-type="fig"}C). Addition of increasing concentrations of Cyt *c* to the assay produced a Cyt *c* dependent increase of the DHE oxidation rate. Calibration curves for O~2~^·-^ production vs. DHE oxidation were generated using increasing XO concentrations ([Supplementary Fig. S1](#s0100){ref-type="sec"}). Thereafter, we calculated that Cyt *c* was stimulating the NADH-dependent O~2~^·-^ production by SPMV almost 20-fold, reaching a maximum value of 192 ± 41 nmoles/min/mg protein, in comparison to the activity measured in absence of Cyt *c* (10 nmoles/min/mg protein) ([Fig. 1](#f0005){ref-type="fig"}D). The NADH dependent O~2~^·-^ production dependence upon Cyt *c* concentration yielded a *K*~m~ for Cyt *c* stimulation of 0.2 ± 0.03 μM.Fig. 1**Cyt*****c*****stimulated NADH-dependent O**~**2**~^**·-**^**production by SPMV. Panel A** : Kinetics of the NADH dependent DHE oxidation by SPMV measured by fluorescence in the absence and presence of SOD (1 U/mL) and anti- C*b*~5~R antibody (1.5 μg/mL). DHE oxidation was measured at 37 °C in potassium phosphate 20 mM plus DTPA 0.1 mM (pH 7.0), using a Perkin Elmer spectrofluorimeter with 470 nm and 605 nm excitation and emission wavelengths, respectively, and 10 nm excitation and emission slits. Representative traces of DHE oxidation by SPMV (7.5 μg/mL) in the presence of NADH (50 μM), oxidized Cyt *c* (Fe^3+^) (2.5 μM) and DHE (2 μM),in the presence of 1.5 μg/mL anti-C*b*~5~R (dashed line) or 1 U/mL SOD (dotted line) are shown. **Panel B**: Quantification of the inhibition induced by anti-C*b*~5~R (1.5 μg/mL) and SOD (1 U/mL) on the DHE oxidation rate by SPMV (7.5 μg/mL) in the presence of NADH (50 μM) and oxidized Cyt *c* (Fe^3+^) (2.5 μM). **Panel C**: Dependence of the NADH-dependent DHE oxidation rate by SPMV (7.5 μg/mL) upon Cyt *c* concentration in the absence (filled squares) or in the presence of SOD (1 U/mL) (open squares). **Panel D**: NADH dependent O~2~^·-^ production by SPMV (7.5 μg/mL) dependence upon Cyt *c* concentration, measured with DHE. All the results shown in this Figure are the average (± standard errors) of experiments done by triplicate.Fig. 1

3.2. Measurement of the O~2~^·-^ production by recombinant C*b*~5~R isoforms {#s0070}
----------------------------------------------------------------------------

### 3.2.1. O~2~^·-^ production by Cb~5~R {#s0075}

The oxidation of NADH by soluble and membrane purified C*b*~5~R isoforms ([Fig. 2](#f0010){ref-type="fig"} and Supp. [Fig. S2A](#s0100){ref-type="sec"}, respectively) was linearly dependent upon protein concentration ([Fig. 2](#f0010){ref-type="fig"}D). The calculated NADH oxidase activity of soluble and membrane C*b*~5~R was 0.27 ± 0.02 and 0.15 ± 0.02 μmoles/min/mg of protein, respectively. Under the same experimental conditions the kinetics of O~2~ consumption, in the presence of NADH, by the soluble and membrane isoform of C*b*~5~R ([Fig. 2](#f0010){ref-type="fig"}B and Supp. [Fig. S2B](#s0100){ref-type="sec"}, respectively) yielded an O~2~ consumption rate of 0.54 ± 0.02 and 0.33 ± 0.04 μmoles/min /mg protein for soluble and membrane C*b*~5~R respectively, calculated from the linear regression plot obtained with increasing enzyme concentrations ([Fig. 2](#f0010){ref-type="fig"}E). O~2~^·-^ was measured from the SOD-inhibited NBT reduction ([Fig. 2](#f0010){ref-type="fig"}C and Supp. [Fig. S2C](#s0100){ref-type="sec"}), yielding a rate of O~2~^·-^ production by soluble and membrane C*b*~5~R of 0.49 ± 0.02 and 0.26 ± 0.02 μmoles/min /mg of protein, respectively, from the slope of the linear dependence with C*b*~5~R concentration ([Fig. 2](#f0010){ref-type="fig"}F). Thus, these results yielded a stoichiometry of ≈ 2 molecules of O~2~^·-^ generated per molecule of oxidized NADH and a good coherence for the results obtained with these three methods.Fig. 2**Correlation between NADH oxidation, O**~**2**~**consumption and superoxide anion production by soluble C*****b***~**5**~**R. Panel A** : Representative traces of the NADH oxidation by soluble C*b*~5~R (2.5 and 5 μg/mL) are shown. NADH oxidase activity was measured from absorbance decay at 340 nm at 37 °C, in the following assay medium (pH 7.0): potassium phosphate 20 mM, DTPA 0.1 mM, NADH 100 μM in presence of soluble C*b*~5~R 2.5 (black line) and 5 μg/mL (grey line). Dotted lines indicate the slopes used to calculate the activity. **Panel B**: Oxygen consumption kinetics for soluble C*b*~5~R 1 μg/mL (black line) 5 μg/mL (grey line). The reaction was started by addition of C*b*~5~R at the time marked by a large drop of trace signals. O~2~ consumption was measured in presence of soluble C*b*~5~R using a Oxygraph Plus DW1 (Hansatech Instruments) electrode, filled with 2 mL of the assay medium indicated in the Panel A. Dotted lines indicate the slopes used to calculate the activity. **Panel C:** O~2~^·-^ production by soluble C*b*~5~R was measured with NBT. Representative traces for the kinetics of NBT reduction by soluble C*b*~5~R isoform, and sensitivity to SOD is shown. NBT reduction was measured at 37 °C at 560 nm with soluble C*b*~5~R 2.5 μg/mL in absence (black line) or presence of SOD 1 U/mL (dotted line) in the assay medium indicated in the Panel A, supplemented with NBT 200 μM. The dotted line indicates the slope used to calculate the activity. **Panels D, E and F**: Dependence upon C*b*~5~R concentration for soluble (filled squares) and membrane (open squares) C*b*~5~R, respectively, of NADH oxidation, oxygen consumption and superoxide production. All the results shown in this Figure are the average (± standard errors) of triplicate experiments.Fig. 2

Cyclic voltammetry can be used for experimental assessment of O~2~^·-^ production [@bib12], [@bib13], [@bib14], [@bib15], [@bib16]. On these grounds, we have used this technique to further confirm O~2~^·-^ production by C*b*~5~R. The measurement of this radical was first calibrated using KO~2~ as a model compound. Two peaks appeared dependent on two generated components over the control: one at 1.25 V and another one at 0.8 V that were assigned to O~2~^·-^ and O~2~, respectively ([Fig. 3](#f0015){ref-type="fig"}A). In presence of C*b*~5~R (panel B), a signal similar to the observed for O~2~^·-^ (using KO~2~) appears, at the same potential, and the O~2~ signal decreased correlating with O~2~ consumption by the enzyme to generate O~2~^·-^. In presence of SOD, the O~2~^·-^ measured signal generated by C*b*~5~R was equal to control (panel 3C).Fig. 3**Qualitative measurement of the O**~**2**~^**·-**^**production by soluble C*****b***~**5**~**R using cyclic voltammetry.** Representative voltammograms of KO~2~ added to the buffer (continuous line) vs its absence (dashed line) measured using thin layer technique with a membrane (cut off 3.5 kDa) with control/albumin is shown in **panel A**. Electrolyte: 20 mM Phosphate buffer / 0.1 M KCl pH 7.0 in presence of atmospheric O~2~. Scan rate: 5 mV/s. Proteins concentration: 0.1 mM. Layer thickness approx. 18 mm. **Panel B**: Typical voltammograms of C*b*~5~R (continuous line) vs. the control/albumin (dashed line) using thin layer technique with a membrane (Cutoff 3.5 kDa), recorded under the same conditions of Panel **A. Panel C**: Effect of SOD addition over the O~2~^·-^ production by soluble C*b*~5~R. Representative voltammograms in the presence of SOD 0.1 U/mL (dotted line) vs. control/albumin (dashed line) are compared to the ones obtained for soluble C*b*~5~R (0.1 mM) (black line) vs. soluble C*b*~5~R (0.1 mM) in presence of SOD (0.1 U/mL) (grey line). Conditions were the same used in previous panels. All the results shown in this Figure are representative of triplicate experiments.Fig. 3

### 3.2.2. Cyt c stimulated O~2~^·-^ production by Cb~5~R {#s0080}

The NADH-dependent DHE oxidation rate by purified C*b*~5~R was almost completely inhibited by the presence of SOD in the assay medium ([Fig. 4](#f0020){ref-type="fig"}A). The Cyt *c* stimulated O~2~^·-^ production by C*b*~5~R (1 mg/mL) was also reliably monitored with DHE ([Fig. 4](#f0020){ref-type="fig"}B) by the dependence upon Cyt *c* (Fe^3+^) of the initial DHE oxidation rate. As Cyt *c* reduction has also been used as an indicator to monitor O~2~^·-^ production [@bib17], [@bib18], we have experimentally assessed whether the SOD inhibited reduction of Cyt *c* can reliably monitor the NADH-dependent O~2~^·-^ production by purified C*b*~5~R. The kinetics of Cyt *c* reduction by C*b*~5~R in absence (continuous line) and presence of SOD (dashed line) is shown in [Fig. 4](#f0020){ref-type="fig"}C. These results showed that SOD (1 U/mL) inhibits by 40-45 % the reduction of Cyt *c* upon incubation in the assay for 45 min, and about the same reduction of the initial rate of reduction up to 5--10 min. This result is in contrast with the almost complete inhibition by SOD (1 U/ml)of the Cyt *c* stimulated DHE oxidation by C*b*~5~R, and pointed out that the reduction of Cyt *c* was the sum of two different kinetic processes: (1) direct reduction by C*b*~5~R which can use Cyt *c* as a final electron acceptor, and (2) reduction of Cyt *c* by the O~2~^·-^ released by C*b*~5~R.Fig. 4**DHE oxidation by C*****b***~**5**~**R is almost completely inhibited by SOD and Cyt*****c*****stimulated O**~**2**~^**·-**^**production by C*****b***~**5**~**R. Panel A**: Kinetics of DHE oxidation by soluble C*b*~5~R (continuous line) vs. blank (dashed line) in absence (black line) and presence of 1 U/mL SOD (grey line). DHE oxidation was measured at 37 °C in the following assay medium (pH 7.0): potassium phosphate 20 mM, DTPA 0.1 mM, NADH 50 μM and 2 μM DHE, with a fixed reductase concentration (1 μg/mL or 27.6 nM). Excitation and emission wavelengths 470 nm and 605 nm, respectively, and 10 nm excitation and emission slits. **Panel B:** Kinetics of DHE oxidation by soluble C*b*~5~R sensitive to SOD (1 U/mL), in the presence of increasing Cyt *c* concentrations. DHE oxidation was measured as indicated above, in the presence of the Cyt *c* concentrations listed in the figure. The traces shown are averages of experimental triplicates. **Panel C**: Representative traces for the kinetics of Cyt *c* reduction by soluble (black line) and membrane C*b*~5~R (grey line) with Cyt *c* (3.75 μM), in the absence (continuous lines) and presence (dashed lines) of SOD 1 U/mL. Cyt *c* reduction was measured at 550 nm at 37 °C in the following assay medium (pH 7.0): potassium phosphate 20 mM, DTPA 0.1 mM, Cyt *c* 3.75 μM and NADH 100 μM, with soluble or membrane C*b*~5~R (0.1 μg/mL). **Panel D**: The O~2~^·-^ production rate by soluble (filled squares) and membrane (open squares) C*b*~5~R dependence upon Cyt *c* is shown. The DHE oxidation rate was measured as indicated in the Panel **A**, with a fixed C*b*~5~R (1 μg/mL or 27.6 nM)) and DHE concentration (2 μM) in the assay medium. **Panel E**: The O~2~^·-^ production by soluble (filled squares) and membrane (open squares) C*b*~5~R isoforms dependence upon DHE concentration is shown. The DHE oxidation rate was measured as indicated in the Panel A, with a fixed C*b*~5~R concentrations(1 μg/mL or 27.6 nM) and Cyt *c* (2.5 μM). **Panel F**: Soluble (filled squares) and membrane C*b*~5~R (open squares) flavin autofluorescence dependence upon Cyt *c* concentration. Cyt *c* elicits a large increase of C*b*~5~R-flavin autofluorescence that allows measuring C*b*~5~R: Cyt *c* complex formation by fluorescence. Y-axis: molar fraction of C*b*~5~R saturated with Cyt *c*, which has been calculated as follows: ΔF/ΔF~max~ = (F-F~0~)/(F~max~-F~0~), where F is the fluorescence intensity at each Cyt *c* concentration, and F~0~ and F~max~ are the fluorescence intensity in the absence and saturating concentrations of Cyt *c*, respectively. Fluorescence measurements were performed at 37 °C in the following buffered solution (pH 7.0): 20 mM potassium phosphate, 1 mM EDTA, and 2 μM C*b*~5~R. Excitation and emission wavelengths 470 nm and 520 nm, respectively, with excitation and emission slits of 10 nm. The averages (± standard errors) of triplicate experiments are shown. Solid and dashed lines are the best non-linear squares fit to the one-binding site equation (F-F~0~)/(F~T~ -F~0~) = \[Cyt *c*\]/(*K*~d~+\[Cyt *c*\]), and yielded values of R^2^ = 0.99 and 0.98, respectively, for soluble (black line) and membrane (grey line) C*b*~5~R isoforms.Fig. 4

Therefore, for a proper kinetic analysis of O~2~^·-^ production we measured the dependence of the DHE oxidation rate upon Cyt *c* and DHE concentration, using a fixed C*b*~5~R concentration and a fixed concentration of one of the twosubstrates for O~2~^·-^ detection, as indicated in the [Supp. material](#s0100){ref-type="sec"}. The data were fit to a two substrate Michaelis-Menten kinetic model ([Fig. 4](#f0020){ref-type="fig"} D and E). To calculate the O~2~^·-^ production, we calibrated the oxidation of DHE by XA/XO (Supp. [Fig. 1](#f0005){ref-type="fig"}B and C). From titration results with different Cyt *c* concentrations and fixed DHE (2 μM) and C*b*~5~R (1 μg/mL) concentration, we calculated a *k*~cat~ for O~2~^·-^ production by soluble and membrane C*b*~5~R of 1.37 ± 0.02 and 1.17 ± 0.02 s^−1^, with a *K*~m~ for Cyt *c* of 0.29 ± 0.01 and 0.42 ± 0.02 μM, respectively ([Fig. 4](#f0020){ref-type="fig"}D). From titration with different DHE concentrations and fixed Cyt *c* (2.5 μM) and C*b*~5~R (1 μg/mL) concentrations, we calculated a *k*~cat~ for O~2~^·-^ production by soluble and membrane C*b*~5~R of 1.45 ± 0.11 and 1.49 ± 0.03 s^−1^ and a *K*~m~ for DHE of 0.19 ± 0.01 and 0.25 ± 0.04 μM, respectively ([Fig. 4](#f0020){ref-type="fig"}E).

3.3. Measurement of C*b*~5~R and Cyt *c* dissociation constant {#s0085}
--------------------------------------------------------------

The results shown above pointed out that Cyt *c* behaves as a redox partner of C*b*~5~R, opening the possibility to use flavin autofluorescence of C*b*~5~R to measure the interaction between these two proteins, see e.g. [@bib5].[Fig. 4](#f0020){ref-type="fig"}F shows C*b*~5~R flavin autofluorescence intensity dependence upon Cyt *c* concentration, yielding a large increase of the fluorescence intensity, i.e. between 60 % and 300 % for soluble C*b*~5~R and for membrane C*b*~5~R, at saturating concentration of Cyt *c* (5 μM). These results revealed that Cyt *c* interaction with C*b*~5~R can be appropriately monitored by C*b*~5~R flavin autofluorescence. The data can be fit to a hyperbolic curve as indicated in the Material and Methods section, yielding a dissociation constant of the Cyt *c*/C*b*~5~R complex of 0.40 ± 0.05 and 0.38 ± 0.02 μM for soluble and membrane C*b*~5~R, respectively. Scatchard plot analysis (Supp. [Fig. S3](#s0100){ref-type="sec"}) is consistent with the binding of one Cyt *c* molecule per C*b*~5~R molecule for soluble and membrane isoforms.

4. Discussion {#s0090}
=============

A scheme or the reactions described in this manuscript is shown in Supp. Fig. S4. Our data demonstrate that C*b*~5~R can use O~2~ as an electron acceptor using NADH as substrate. Although the use of DHE formeasurement of O~2~^·-^ has been stated to be useful for qualitative purposes in biological systems [@bib19], we achieved to quantify O~2~^·-^ production by purified C*b*~5~R with DHE, using proper controls (i.e. calibrating the signal with XA/XO in the presence of a large amount of catalase that avoid E^+^ formation when H~2~O~2~ is also produced) as shown in other reports [@bib10], [@bib11], [@bib20]. Stoichiometric ratios between NADH and O~2~ consumption indicated that C*b*~5~R uses one NADH molecule to reduce two O~2~ molecules. Moreover, the values obtained for O~2~^·-^ production correlated with O~2~ consumption, indicating that the O~2~ consumption is mainly due to O~2~^·-^ production ([Table 1](#t0005){ref-type="table"}). With the use of an anti-C*b*~5~R antibody, we confirmed that C*b*~5~R was responsible of the Cyt *c* (Fe^3+^) stimulated production by SPMV, since 90 % of the O~2~^·-^ production was blocked by addition of specific antibodies against C*b*~5~R, added to the assay. As cytochrome P450s also display NAD(P)H-dependent production of O~2~^.-^ [@bib21] and some cytochrome P450 isoforms are associated the plasma membrane [@bib22], it is likely that cytochrome P450s account for most of the C*b*~5~R-independent O~2~^.-^ production [@bib22], [@bib23], although we cannot discard other O~2~^.-^ sources. Our results also show that Cyt *c* binds to purified C*b*~5~R isoforms with dissociation constants similar to the *K*~m~ values for the Cyt *c* stimulated O~2~^·-^ production by C*b*~5~R isoforms and close to the *K*~m~ value obtained from the NADH-dependent production of O~2~^·-^ by SPMV.Table 1O~2~^·-^ production by human C*b*~5~R.Table 1Soluble C*b*~5~RMembrane C*b*~5~R(μmoles/min /mg protein)(μmoles/min /mg protein)NADH oxidase0.27 ± 0.020.15 ± 0.02O~2~ consumption0.54 ± 0.020.33 ± 0.04O~2~^·-^ production (SOD-inhibited NBT reductase)0.49 ± 0.020.26 ± 0.02Cyt *c* stimulated O~2~^·-^ production (DHE)4.1 ± 0.2[a](#tbl1fna){ref-type="table-fn"}3.5 ± 0.3[a](#tbl1fna){ref-type="table-fn"}Cyt *c* stimulated O~2~^·-^ production (DHE)4.4 ± 0.1[b](#tbl1fnb){ref-type="table-fn"}3.8 ± 0.4[b](#tbl1fnb){ref-type="table-fn"}[^1][^2]

In the context of apoptosis, the function of Cyt *c* reduction by C*b*~5~R can be seen as part of the cellular defense system, because this protein shows a widespread subcellular membrane localization, namely, endoplasmic reticulum, outer mitochondrial membrane and plasma membrane [@bib24]. Cyt *c* reduction blocks apoptosis since its role in this type of cell death has been mainly attributed to the oxidized form [@bib25], [@bib26], [@bib27]. For this reason, systems with ability to reduce Cyt *c* have an intrinsic anti-apoptotic function. Noteworthy, the payback for this reduction exerted by C*b*~5~R is the formation of O~2~^·-^, a radical also described to be formed in mitochondria upon Cyt *c* release [@bib28].

Appendix A. Supplementary material {#s0100}
==================================

Supplementary material **Fig. S1. Calibration curves for O**~**2**~^**·-**^**production vs DHE oxidation. Panel A:** The DHE oxidation rate at 37 °C was calibrated with XA (0.4 mM) with increasing concentrations of XO (18, 36, and 52 mU/mL) in the following assay medium (pH 7.0): potassium phosphate 20 mM, DTPA 0.1 mM, pluscatalase (3 U/mL) and NADH 50 μM. **Panel B**: XA/XO (same concentrations used above) was used to calibrate the O~2~^·-^ production using the SOD-sensitive Cyt c reduction assay under the same conditions of Panel A, in the absence and presence of 1 U/mL of SOD. **Panel C**: Calibration curve for DHE oxidation rates in the presence of XA (0.5 mM) at fixed XO concentrations (16, 36 and 52 mU/mL of XO) vs superoxide anion production measured by the reduction of Cyt *c* inhibited by SOD at the same XA/XO concentrations. All the results shown in this Figure are the average (± standard errors) of triplicate experiments. Dashed lines indicate the best linear regression fits, R^2^ 0.99 in all cases. **Fig. S2. Correlation between NADH, oxygen consumption and superoxide anion production by membrane C*****b***~**5**~**R. Panel A**: Representative traces for NADH oxidation by membrane C*b*~5~R measured at 340 nm and 37 °C, in the following assay medium (pH 7.0) potassium phosphate 20 mM, DTPA 0.1 mM and NADH 100 μM, in presence of membrane C*b*~5~R 2.5 (black line) and 5 μg/mL (grey line). Dashed lines are the slopes used to calculate the NADH oxidase activity. **Panel B**: O~2~ consumption kinetics at 37 °C for membrane C*b*~5~R 1 μg/mL (black line) 5 μg/mL (grey line) measured with an Oxygraph Plus DW1 (Hansatech Instruments) electrode, filled with 2 mL of the assay medium indicated in Panel A. The large drop of the traces monitors the time at which C*b*~5~R was added and dashed lines are the slopes used to calculate the O~2~ consumption activity. **Panel C**: O~2~^·-^ production by membrane C*b*~5~R measured with NBT. Representative traces for the kinetics of NBT reduction (wavelength 560 nm) by 2.5 μg/mL of the membrane C*b*~5~R isoform at 37 °C in the assay medium, indicated in Panel A, supplemented with NBT 200 μM, in absence (black line) or presence (dotted line) of SOD 1 U/mL. The dashed line indicates the slope used to calculate the initial NBT reduction rate. All the results shown in this Figure are representative of triplicate experiments. **Fig. S3. Determination of the stoichiometry of the human C*****b***~**5**~**R: C*****b***~**5**~**complex.** The C*b*~5~R-flavin fluorescence was titrated with Cyt *c* at different soluble (**Panel A**) and membrane (**Panel B**) C*b*~5~R concentrations at 37 °C in potassium phosphate 20 mM plus DTPA 0.1 mM buffer (pH 7.0). C*b*~5~R concentrations: 1 μM (square), 2 μM (circle) and 5 μM (up triangle), for soluble (filled symbols) and membrane isoforms (open symbols). Fluorescence intensity was measured with 470 nm and 520 nm excitation and emission wavelengths, respectively, and 10 nm excitation and emission slits. **Panel C**: The fluorescence intensity increase (F-F~0~) of soluble and membrane C*b*~5~R autofluorescence dependence upon Cyt *c* concentration (symbols indicate the same C*b*~5~R concentrations used in Panels A and B). All curves for C*b*~5~R autofluorescence dependence upon Cyt *c* fit well to an hyperbolic curve (dashed line), with non-statistically significant differences in the half saturation value, pointing out that the binding affinity was not significantly altered in the C*b*~5~R concentration range used in these assays. **Panel D**: Scatchard-like plot of the data obtained in the C*b*~5~R-flavin fluorescence titration with Cyt *c* assuming a 1:1 stoichiometric ratio of the complex C*b*~5~R:C*b*~5~. Bound and free \[Cyt *c*\] have been calculated as follows: \[Cyt *c*\]~bound~ = molar fraction of C*b*~5~R saturated with Cyt *c* x \[Cyt *c*\]~total~, and \[Cyt *c*\]~free~ = \[Cyt *c*\]~total~ -\[Cyt *c*\]~bound~. The molar fraction of C*b*~5~R saturated with Cyt *c* has been calculated as follows ΔF/ΔF~max~ = (F-F~0~)/(F~max~-F~0~), where F is the fluorescence intensity at each Cyt *c* concentration, and F~0~ and F~max~ are the fluorescence intensity in the absence and saturating concentrations of Cyt *c*, respectively. The data lead to a value of 1.0 ± 0.07 for the intercept with the X-axis, meaning 1 C*b*~5~ binding site per C*b*~5~R molecule. The average of the plots obtained at different C*b*~5~R concentrations is shown as a continuous line and SD error is shown as dashed lines. **Fig. S4. O**~**2**~^**·-**^**production by C*****b***~**5**~**R (panel A) and its stimulation by Cyt*****c*****(panel B) upon complex formation with Cyt*****c***. Panel A shows the production of O~2~^·-^ (red) by C*b*~5~R (yellow backbone) (PDB file: 1UMK, is the surface representation of the crystal model for erythrocyte NADH-C*b*~5~R) using NADH and O~2~ as substrates (in black). Panel B shows the two observed pathways for Cyt *c* reduction (pink backbone) by C*b*~5~R upon complex formation with oxidized Cyt *c* (Fe^3+^) (dark red backbone). Cyt *c* can be reduced through electron transfer from C*b*~5~R or through the stimulated superoxide anion production generated upon formation of the complex between C*b*~5~R and Cyt *c*. In both cases NADH is used as a substrate. Arrow thickness indicates the stimulation of activities.

Supplementary material

This work was supported by the Unidade de Ciências Biomoleculares Aplicadas-UCIBIO, which is financed by national funds from FCT/MEC (UID/Multi/04378/2013) and co-financed by the ERDF under the PT2020 Partnership Agreement (POCI-01--0145-FEDER-007728). Experimental work was also partially supported by funding from Grant BFU2014-53641-P of the Spanish Ministerio de Economía y Competitividad and Ayuda a Grupos de la Junta de Extremadura (GR15139 to Group BBB008) co-financed by the European Funds for Structural Development (FEDER). AKSA and SF thank FCT/MCTES for the post-doctoral and pre-doctoral fellowship grants (SFRH/BPD/100069/2014 and SFRH/BD/84543/2012, respectively), which are financed by national funds and co-financed by FSE. We would like to thank Susana Ramos for her initial assistance in the preparation of the membrane isoform of C*b*~5~R.

Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.redox.2017.11.021](http://doi:10.1016/j.redox.2017.11.021){#ir0005}.

[^1]: Values calculated by fitting the data obtained with DHE to one substrate Michaelis-Menten kinetics.

[^2]: Values calculated by fitting the data obtained with DHE to two substrates Michaelis-Menten kinetics.
